# FDA Approves Torrent's ANDA Application Torrent Pharmaceuticals has received FDA approval for its abbreviated new drug application (ANDA211537), expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive U.S. pharmaceutical landscape. The approval strengthens Torrent's ability to compete across multiple therapeutic categories and could enhance revenue streams through increased generic drug distribution.